Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

N-acetylcysteine for preventing ototoxicity in hemodialysis patients receiving gentamicin

Nature Clinical Practice Nephrology volume 3, pages 478–479 (2007)Cite this article

boxed-text Feldman L et al. (2007) Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine. Kidney Int [doi:10.1038/sj.ki.5002295]

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Saxena AK et al. (2002) Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock. Pharmacotherapy 22: 105–108

    Article  Google Scholar 

  2. Rybak LP and Kelly T (2003) Ototoxicity: bioprotective mechanisms. Curr Opin Otolaryngol Head Neck Surg 11: 328–333

    Article  Google Scholar 

  3. Edson RS and Terrell CL (1999) The aminoglycosides. Mayo Clin Proc 74: 519–528

    Article  CAS  Google Scholar 

  4. Saxena AK and Panhotra BR (2005) Haemodialysis catheter-related bloodstream infections: current treatment options and strategies for prevention. Swiss Med Wkly 135: 127–138

    PubMed  Google Scholar 

  5. Saxena AK and Panhotra BR (2005) Locking hemodialysis catheters with cefotaxime instead of gentamicin to avoid potential ototoxicity. Kidney Int 67: 2505–2506

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Al-Rahba Hospital, Health Authority of Abu Dhabi, Department of Medicine/Nephrology, PO Box 34555, Abu Dhabi, United Arab Emirates dranil_31982@yahoo.com

Authors and Affiliations

  1. AK Saxena is a Specialist Renal Physician in the Nephrology, Hypertension and Dialysis section of Al-Rahba Hospital, Health Authority of Abu Dhabi, Abu Dhabi, United Arab Emirates.,

    Anil K Saxena

Authors
  1. Anil K Saxena
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saxena, A. N-acetylcysteine for preventing ototoxicity in hemodialysis patients receiving gentamicin. Nat Rev Nephrol 3, 478–479 (2007). https://doi.org/10.1038/ncpneph0572

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0572

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing